vipul jairath
Western University
H-index: 60
North America-Canada
Top articles of vipul jairath
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
P932 Corticosteroid-sparing effect of mirikizumab for the treatment of moderately-to-severely active Ulcerative Colitis: Extended induction subgroup analysis from Phase 3 trial | Journal of Crohn's and Colitis | D Laharie C Siegel P Dulai K Matsuoka J Gisbert | 2024/1/1 |
Impact of Treatment Response on Risk of Serious Infections in Patients With Crohn’s Disease: Secondary Analysis of the PYRAMID Registry | Clinical Gastroenterology and Hepatology | Dhruv Ahuja Jiyu Luo Yuchen Qi Gaurav Syal Brigid S Boland | 2024/1/11 |
IMPACT OF TREATMENT RESPONSE WITH ADALIMUMAB ON RISK OF SERIOUS INFECTIONS IN PATIENTS WITH CROHN’S DISEASE: SECONDARY ANALYSIS OF THE PYRAMID REGISTRY | Gastroenterology | Dhruv Ahuja Jiyu Luo Yuchen Qi Gaurav Syal Brigid Boland | 2024/2/1 |
Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort study | EClinicalMedicine | Mariangela Allocca Cecilia Dell’Avalle Alessandra Zilli Federica Furfaro Ferdinando D'Amico | 2024/5/1 |
Identification of immune cell markers associated with ulcerative colitis histological disease activity in colonic biopsies | Journal of Clinical Pathology | Pavine LC Lefevre Zhongya Wang Wendy Teft Guangyong Zou Tanja Van Viegen | 2024/2/28 |
OC. 07.3: CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH MIRIKIZUMAB MAINTENANCE THERAPY | Digestive and Liver Disease | D Laharie CA Siegel K Samaan DA Fisher N Morris | 2024/4/1 |
Matching-Adjusted Indirect Comparisons of Filgotinib vs Vedolizumab, Tofacitinib, and Ustekinumab for Moderately to Severely Active Ulcerative Colitis | Inflammatory Bowel Diseases | Xiaoyan Lu Zheng-Yi Zhou Yiqiao Xin Min-Jung Wang Emma Gray | 2024/1/1 |
Propofol sedation does not improve measures of colonoscopy quality but increase cost–findings from a large population-based cohort study | Eclinicalmedicine | Sheikh Rahman Lauren E Cipriano Cassandra McDonald Sarah Cocco Ziad Hindi | 2024/4/1 |
Endoscopic and Histological Placebo Rates in Crohn’s Disease Clinical Trials: A Systematic Review and Meta-analysis | Sudheer K Vuyyuru Tran M Nguyen Malcolm Hogan Tim Raine Nurulamin M Noor | 2024/4/1 | |
A255 COMMUNICATING NEEDS AND FEATURES OF IBD EXPERIENCES (CONFIDE) SURVEY: PATIENT PERSPECTIVES ON EXPERIENCE OF ULCERATIVE COLITIS SYMPTOMS IN CANADA | Journal of the Canadian Association of Gastroenterology | J Glass R Panaccione t Bessissow T Hunter Gibble C Atkinson | 2024/3/1 |
Severe Ulcerative Colitis Complicated by Malakoplakia Resulting in Proctocolectomy | ACG Case Reports Journal | Lotus Alphonsus Theshani A De Silva David Driman Vipul Jairath | 2024/1/1 |
OP01 PROFILE: a multi-centre, randomised, open-label, biomarker-stratified clinical trial of treatment strategies for patients with newly-diagnosed Crohn’s disease | Journal of Crohn's and Colitis | N Noor J Lee S Bond F Dowling B Brezina | 2024/1/1 |
P689 Adaptive steroid tapering impedes corticosteroid-free remissions compared to forced tapering in UC clinical trials | Journal of Crohn's and Colitis | N Narula H Hamam EC Wong JK Marshall V Jairath | 2024/1/1 |
P849 Bayesian network meta-analysis of the efficacy of advanced therapies for patients with moderately to severely active ulcerative colitis naïve to advanced therapy | Journal of Crohn's and Colitis | V Jairath TP Leahy R Potluri K Wosik D Gruben | 2024/1/1 |
OP40 Transcriptomic signature of response to vedolizumab in patients with moderate-to-severe ulcerative colitis: Results from an international, multicentre, retrospective … | Journal of Crohn's and Colitis | B Linggi A Salas M Veny K Borowski MS Silverberg | 2024/1/1 |
P952 Why do patients with Inflammatory Bowel Disease Take Part in Pharmaceutical Clinical Trials? A qualitative study of Clinical Trial Participants | Journal of Crohn's and Colitis | V Solitano H Prins M Archer L Guizzetti V Jairath | 2024/1/1 |
Unresolved challenges in acute severe ulcerative colitis | Indian Journal of Gastroenterology | Sudheer K Vuyyuru Vipul Jairath | 2024/1/8 |
Determining the optimal treatment target in patients with ulcerative colitis: rationale, design, protocol and interim analysis for the randomised controlled VERDICT trial | BMJ Open Gastroenterology | Vipul Jairath Guangyong Zou Zhongya Wang Shashi Adsul Jean-Frederic Colombel | 2024/2/1 |
Reliability and Responsiveness of Clinical and Endoscopic Outcome Measures in Crohn’s Disease | Inflammatory Bowel Diseases | Reena Khanna Brian G Feagan Guangyong Zou Larry W Stitt John WD McDonald | 2024/4/25 |
Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated with Low Risk of Disease Progression | Clinical Gastroenterology and Hepatology | Neeraj Narula Emily CL Wong Parambir S Dulai Jaiminkumar Patel John K Marshall | 2024/2/28 |
